Bildkälla: Stockfoto

Paxman: CIPN included in a study - Redeye

Redeye is pleased that Paxman announced yesterday that the Paxman Limb Cryocompression System (PLCS) would be used in a prospective study looking at the prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN). This is as we see it real progress in this field, and if successful, the study would prove a significant step forward in the CIPN area.

Redeye is pleased that Paxman announced yesterday that the Paxman Limb Cryocompression System (PLCS) would be used in a prospective study looking at the prevention of Chemotherapy-Induced Peripheral Neuropathy (CIPN). This is as we see it real progress in this field, and if successful, the study would prove a significant step forward in the CIPN area.
Börsvärldens nyhetsbrev
ANNONSER